Drug Database
Back to search

Ireland· IE-PA-PA23355/019/001

Colofac 135 mg Tablets

A mebeverine product containing mebeverine hydrochloride, registered in Ireland by Viatris Healthcare Limited. The same ATC class is registered in 13 of our 19 countries.

ATC A03AA04

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedColofac 135 mg TabletsATCA03AA04REGISTER NO.IE-PA-PA23355/019/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mebeverine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Mebeverine is registered in 13 of 19 countries.

Countries holding a registration under ATC A03AA04 (mebeverine), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose
Search mebeverine products by name

Mebeverine · ATC A03AA04

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mebeverine costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.20 in France to $1.31 in Switzerland — a ×6.5 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Mebeverine · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.31
  • FR France$0.20
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Mebeverine hydrochloride
Manufacturer
Viatris Healthcare Limited
Country
Ireland (IE)
ATC code
A03AA04
ATC class
Mebeverine
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA23355/019/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mebeverine in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mebeverine products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Colofac, Colofac Retard
  • Belgium · Duspatalin, Duspatalin Retard
  • Bulgaria · Дуспаверин, Дуспаталин
  • Cyprus · Medoverine, Spasverin
  • Czechia · Duspatalin Retard
  • Germany · Duspatal, Duspatal Retard
  • Denmark · Duspatalin Retard
  • Estonia · Mebeverine Sanoswiss
  • Spain · Duspatalin, Mebeverina Tarbis
  • France · Duspatalin, Mebeverine Zentiva
  • United Kingdom (Northern Ireland) · Aurobeverine Mr, Boots Ibs Symptom Relief
  • Greece · Duspatalin
  • Croatia · Colospa Retard, Rudakol
  • Iceland · Duspatalin Retard
  • Italy · Duspatal
  • Lithuania · Duspatalin, Mebeverine Sanoswiss
  • Luxembourg · Duspatalin, Duspatalin Retard
  • Latvia · Duspatalin, Mebeverine Sanoswiss
  • Malta · Colofac Retard, Mebeverine Hydrochloride Aspire Pharma (Malta)
  • Netherlands · Duspatal, Duspatal Retard
  • Poland · Auroverin Mr, Duspatalin Gastro
  • Portugal · Duspatal Retard, Mebeverina Aristo
  • Romania · Colospasmin, Duspatalin
  • Slovenia · Rudakol
  • Slovakia · Duspatalin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dcb2d7e0-b0d2-438b-a83c-a9d55453429a
GET /v1/drugs/dcb2d7e0-b0d2-438b-a83c-a9d55453429a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "A03AA",
    "A03AA04"
  ],
  "strength": null,
  "pa_number": "PA23355/019/001",
  "substances": [
    "Mebeverine hydrochloride"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "07/02/1983",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": "IC0180-210-040"
}
API referenceMCP serverPlans

See everything about mebeverine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console